Subject AreasNews/In the News
News releases and news clips mentioning Essential Action's work. News Releases Pharmaceutical Industry Transparency Issues Essential Action campaign-related materials to promote transparency around Big Pharma's operations. Trade Agreements Bilateral and regional trade agreements are threatening to strip away the flexibilities that developing countries maintain under international trade rules. World Trade Organization A key concern is how generic drug manufacturers can achieve economies of scale under WTO rules. Country Disputes and Other Issues Seeking to lower medicines prices at the national level. Publications and Papers Links to a variety of published papers on which we have worked recently. Fact Sheets Easy-to-understand materials on key access-to-medicines issues. Home |
Colombia Health Organizations file for compulsory license on lopinavir/ritonavirThursday, July 17. 2008Global Access to Medicines Bulletin: Innovative R&D Reform Agenda adopted at WHOFriday, June 20. 2008Cheaper Medicines for the Public GoodFriday, May 30. 2008WHO: Secretariat's publications policy questioned at Board meetingThursday, May 29. 2008WHO hails pharma R&D “breakthrough”Tuesday, May 27. 2008WHO Plan Will Bridge Dispute Over PatentsSunday, May 25. 2008News Release: Essential Comment at Completion of WHO R&D TalksSaturday, May 24. 2008World Health Assembly Opens On Note Of Global Crises, Hope For IPTuesday, May 20. 2008WHO Publications Policy Proposal Threatens Technical QualityTuesday, May 20. 2008Waxman letter on WHO Publications PolicyMonday, May 19. 2008 |
Resolution Affirming the Doha DeclarationThe U.S. Congress is considering resolutions calling on the administration not to pressure countries using trade rule flexibilities to promote access to medicines, and supporting new mechanisms to promote R&D. Learn more here.
Contact InformationEssential Action's Access to Medicines Project
P.O. Box 19405 Washington, D.C. 20036 USA tel: 1-202-387-8030 fax: 1-202-234-5176 E-mail: Robert Weissman rob@essential.org Jim Donahue jdonahue@essential.org Peter Maybarduk peter.maybarduk@essentialinformation.org Sarah Rimmington srimmington@essentialinformation.org About UsEssential Action's Access to Medicines Project is working to overcome patent and other intellectual property barriers to affordable medicines. Read more About Us
|